Option-related selling at Canopy Growth (WEED)

Option-related selling at Canopy Growth (T:WEED)

Mark Anthony Nicholas Zekulin, a Senior Officer, exercised Options and disposed of 96,405 Common Shares on a direct ownership basis at a price of $19.060 on November 24th, 2017. This represents a $1,837,470 divestment of the company's shares and an account share holdings change of -29.1%.

Earlier on November 22nd, Phillip Shaer, a Senior Officer, also exercised Options and sold 36,667 Common Shares on a direct ownership basis at a price of $19.168. This represents a $702,833 divestment of the company's shares and an account share holdings change of -100.0%.

Canopy Growth is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.

Canopy Growth Corporation, formerly Tweed Marijuana Inc., is a diversified cannabis company. The Company, through its subsidiaries Tweed Inc. (Tweed), Bedrocan Canada Inc. (Bedrocan) and Tweed Farms Inc. (Tweed Farms), is engaged in the business of producing and selling legal marijuana in the Canadian medical market. It is also focusing on producing and selling marijuana in the recreational market in Canada. Its core brands are Tweed and Bedrocan. Tweed is a licensed producer of medical marijuana. Tweed's commercial license covers approximately 168,000 square feet of its Smiths Falls facility and allows Tweed to produce and sell approximately 3,540 kilograms of medical marijuana per year. Tweed's built-out production capacity is over 10 climate controlled indoor growing rooms. Bedrocan is a medical-grade cannabis. Bedrocan's over 52,000 square feet production facility in Toronto, Ontario is licensed, and includes over 30 vegetative and growing rooms, and over three dispensing rooms.